Director, CEO and President · Verrica Pharmaceuticals Inc. · Verrica Pharmaceuticals Inc. — Series C Warrant (right to buy)
Side
BUY
Value
—
Shares
23.6K
Price
—
Executed
Nov 25, 2025
Disclosed
Nov 25, 2025
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Nov 25 executedNov 25, 2025 disclosed
VRCA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Verrica Pharmaceuticals Inc. — Series C Warrant (right to buy)
Ticker
VRCA
Shares
23.6K
Execution date (reported)
Nov 25, 2025
Owned after transaction
23.6K shares
Days from execution to publication
0
What this establishes
Rieger Jayson filed this Form 4 reporting a open-market purchase of VRCA on Nov 25, 2025. It became public on Nov 25, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO and President
Rieger Jaysoncik:0002043558
Issuer
Verrica Pharmaceuticals Inc.cik:0001660334
Revision history · 0
No field has changed since this record was first ingested.
